Search Results - Mehdi, Aminder

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Two schedules of etirinotecan pegol (NKTR-102) in patients with previously treated metastatic breast cancer: a randomised phase 2 study

    Two schedules of etirinotecan pegol (NKTR-102) in patients with previously treated metastatic breast cancer: a randomised phase 2 study by Awada, Ahmad, Dr Prof, Garcia, Agustin A, MD, Chan, Stephen, MD, Jerusalem, Guy H M, Prof, Coleman, Robert E, Prof, Huizing, Manon T, Prof, Mehdi, Aminder, MD, O'Reilly, Sue M, MD, Hamm, John T, MD, Barrett-Lee, Peter J, Prof, Cocquyt, Veronique, Prof, Sideras, Kostandinos, MD, Young, David E, MD, Zhao, Carol, MS, Chia, Yen Lin, PhD, Hoch, Ute, PhD, Hannah, Alison L, MD, Perez, Edith A, Prof

    Published in The lancet oncology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Significant efficacy in a phase 2 study of NKTR-102, a novel polymer conjugate of Irinotecan, in patients with pre-treated metastatic breast cancer (MBC)

    Significant efficacy in a phase 2 study of NKTR-102, a novel polymer conjugate of Irinotecan, in patients with pre-treated metastatic breast cancer (MBC) by Awada, Ahmad, Chan, Stephan, JERUSALEM, Guy, Coleman, Robert E, Huizing, Manon, Mehdi, Aminder, O'Reilly, Susan M, Hamm, John T, Patel, Tejal, Hannah, Alison L, Masuoka, Lorianne K, Garcia, Agustin A, Perez, Edith A

    Get full text
    Web Resource
    Save to List
    Saved in:

Search Tools: